These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9120990)

  • 1. Genetic variations in human benign prostatic hyperplasia detected by restriction landmark genomic scanning.
    Konishi N; Hiasa Y; Matsuda H; Nakamura M; Kitahori Y
    J Urol; 1997 Apr; 157(4):1499-503. PubMed ID: 9120990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different patterns of DNA alterations detected by restriction landmark genomic scanning in heterogeneous prostate carcinomas.
    Konishi N; Hiasa Y; Nakamura M; Kitahori Y; Matsubara K; Nagai H
    Am J Pathol; 1997 Jan; 150(1):305-14. PubMed ID: 9006345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic alterations in human prostate carcinoma cell lines by two-dimensional gel analysis.
    Konishi N; Tao M; Nakamura M; Kitahaori Y; Hiasa Y; Nagai H
    Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1129-35. PubMed ID: 8997517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA fingerprint detection of somatic mutations in benign prostatic hyperplasia and prostatic adenocarcinoma.
    Werely CJ; Heyns CF; Van Velden DJ; Van Helden PD
    Genes Chromosomes Cancer; 1996 Sep; 17(1):31-6. PubMed ID: 8889504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis.
    Nagai H; Ponglikitmongkol M; Mita E; Ohmachi Y; Yoshikawa H; Saeki R; Yumoto Y; Nakanishi T; Matsubara K
    Cancer Res; 1994 Mar; 54(6):1545-50. PubMed ID: 8137261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic analysis of human hepatocellular carcinomas using Restriction Landmark Genomic Scanning.
    Nagai H; Hirotsune S; Komatsubara H; Hatada I; Mukai T; Hayashizaki Y; Matsubara K
    Cancer Detect Prev; 1993; 17(3):399-404. PubMed ID: 8402726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of no tI-cleaved genomic DNA fragments appearing as spots in 2D gel electrophoresis.
    Nagai H; Pongliktmongkol M; Kim YS; Yoshikawa H; Matsubara K
    Biochem Biophys Res Commun; 1995 Aug; 213(1):258-65. PubMed ID: 7639743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic aberrations in early stage human hepatocellular carcinomas.
    Nagai H; Ponglikitmongkol M; Fujimoto J; Yamamoto H; Kim YS; Konishi N; Matsubara K
    Cancer; 1998 Feb; 82(3):454-61. PubMed ID: 9452261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dimensional gel electrophoretograms of human chromosome specific restriction DNA fragments.
    Yoshikawa H; Nagai H; Matsubara K; Fujiyama A
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1566-72. PubMed ID: 8250912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction landmark genomic scanning: analysis of CpG islands in genomes by 2D gel electrophoresis.
    Costello JF; Hong C; Plass C; Smiraglia DJ
    Methods Mol Biol; 2009; 507():131-48. PubMed ID: 18987812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status.
    Akama TO; Okazaki Y; Ito M; Okuizumi H; Konno H; Muramatsu M; Plass C; Held WA; Hayashizaki Y
    Cancer Res; 1997 Aug; 57(15):3294-9. PubMed ID: 9242463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction landmark genomic scanning.
    Ando Y; Hayashizaki Y
    Nat Protoc; 2006; 1(6):2774-83. PubMed ID: 17406534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia.
    Koivisto PA; Schleutker J; Helin H; Ehren-van Eekelen C; Kallioniemi OP; Trapman J
    Clin Cancer Res; 1999 Nov; 5(11):3578-82. PubMed ID: 10589774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer.
    Alberti I; Barboro P; Barbesino M; Sanna P; Pisciotta L; Parodi S; Nicolò G; Boccardo F; Galli S; Patrone E; Balbi C
    J Cell Biochem; 2000 Sep; 79(3):471-85. PubMed ID: 10972984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome aberrations observed by restriction landmark genome scanning analysis of chromosomal DNA in various types of primary hepatocellular carcinoma.
    Hanafusa T; Yumoto Y; Mimura T; Shinji T; Hada H; Koide N; Tsuji T
    Hepatogastroenterology; 2002; 49(44):482-6. PubMed ID: 11995478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia.
    Müller I; Urban K; Pantel K; Schwarzenbach H
    Ann N Y Acad Sci; 2006 Sep; 1075():222-9. PubMed ID: 17108215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.